Roundtable Lunch Session: Crystal Clear? More About Clearing.

02 Dec 2010 12:00 p.m. - 01:30 p.m.

Morrison & Foerster LLP
1290 Avenue of the Americas
39th floor
New York, NY 10104
Christie Adams
(212) 336-4024

A prominent element of regulatory reform in the US and in Europe is the movement of OTC derivatives to centralized clearing. The use of clearinghouses has been advanced as a panacea; however, many questions remain to be answered. We will focus on the clearing requirements under the Dodd-Frank Act, issues raised in dealing with CCPs, and related questions for dealers and for end-users.

Speaker: David H. Kaufman

New York CLE credit is pending.




Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.